Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Behavioral and Brain Functions
Published in: Behavioral and Brain Functions 1/2008

Open Access 01-12-2008 | Research

Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level

Authors: Nicholas C Stefanis, Thomas A Trikalinos, Dimitrios Avramopoulos, Nikos Smyrnis, Ioannis Evdokimidis, Evangelia E Ntzani, Alex Hatzimanolis, John PA Ioannidis, Costas N Stefanis

Published in: Behavioral and Brain Functions | Issue 1/2008

Login to get access

Abstract

Background

While association studies on schizophrenia show conflicting results regarding the importance of the regulator of the G-protein signaling 4 (RGS4) gene, recent work suggests that RGS4 may impact on the structural and functional integrity of the prefrontal cortex. We aimed to study associations of common RGS4 variants with prefrontal dependent cognitive performance and schizotypy endophenotypes at the population level.

Methods

Four RGS4 single nucleotide polymorphisms (SNP1 [rs10917670], SNP4 [rs951436], SNP7 [rs951439], and SNP18 [rs2661319]) and their haplotypes were selected. Their associations with self-rated schizotypy (SPQ), vigilance, verbal, spatial working memory and antisaccade eye performance were tested with regressions in a representative population of 2,243 young male military conscripts.

Results

SNP4 was associated with negative schizotypy (higher SPQ negative factor for common T allele, p = 0.009; p = 0.031 for differences across genotypes) and a similar trend was seen also for common A allele of SNP18 (p = 0.039 for allele-load model; but p = 0.12 for genotype differences). Haplotype analyses showed a similar pattern with a dose-response for the most common haplotype (GGGG) on the negative schizotypy score with or without adjustment for age, IQ and their interaction (p = 0.011 and p = 0.024, respectively). There was no clear evidence for any association of the RGS4 variants with cognitive endophenotypes, except for an isolated effect of SNP18 on antisaccade error rate (p = 0.028 for allele-load model).

Conclusion

Common RGS4 variants were associated with negative schizotypal personality traits amongst a large cohort of young healthy individuals. In accordance with recent findings, this may suggest that RGS4 variants impact on the functional integrity of the prefrontal cortex, thus increasing susceptibility for psychotic spectrum disorders.
Literature
1.
Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, Petursson H, Curtis D: Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet. 2001, 68: 661-673. 10.1086/318788.PubMedCentralCrossRefPubMed
2.
Brzustowicz LM, Hayter JE, Hodgkinson KA, Chow EW, Bassett AS: Fine mapping of the schizophrenia susceptibility locus on chromosome 1q22. Hum Hered. 2002, 54: 199-209. 10.1159/000070665.CrossRefPubMed
3.
Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, B KT, Ferrell RE, Middleton FA, Devlin B, Levitt P, Lewis DA, Nimgaonkar VL: Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet. 2002, 11: 1373-1380. 10.1093/hmg/11.12.1373.CrossRefPubMed
4.
Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, McCreadie RG, Buckland P, Sharkey V, Chowdari KV, Zammit S, Nimgaonkar V, Kirov G, Owen MJ, O'Donovan MC: Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry. 2004, 55: 192-195. 10.1016/j.biopsych.2003.11.002.CrossRefPubMed
5.
Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M, Corvin AP: Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2004, 125: 50-53. 10.1002/ajmg.b.20109.CrossRef
6.
Chen X, Dunham C, Kendler S, Wang X, O'Neill FA, Walsh D, Kendler KS: Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet. 2004, 129: 23-26. 10.1002/ajmg.b.30078.CrossRef
7.
Zhang F, St Clair D, Liu X, Sun X, Sham PC, Crombie C, Ma X, Wang Q, Meng H, Deng W, Yates P, Hu X, Walker N, Murray RM, Collier DA, Li T: Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia. Genes Brain Behav. 2005, 4: 444-448. 10.1111/j.1601-183X.2005.00167.x.CrossRefPubMed
8.
Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE: Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet. 2005, 77: 918-936. 10.1086/497703.PubMedCentralCrossRefPubMed
9.
So HC, Chen RY, Chen EY, Cheung EF, Li T, Sham PC: An association study of RGS4 polymorphisms with clinical phenotypes of schizophrenia in a Chinese population. Am J Med Genet B Neuropsychiatr Genet. 2008, 147B (1): 77-85. 10.1002/ajmg.b.30577.CrossRefPubMed
10.
Brzustowicz LM, Simone J, Mohseni P, Hayter JE, Hodgkinson KA, Chow EW, Bassett AS: Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet. 2004, 74: 1057-1063. 10.1086/420774.PubMedCentralCrossRefPubMed
11.
Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, Egan MF, Gill M, Kendler KS, Kirov G, Heston LL, Levitt P, Lewis DA, Li T, Mirnics K, Morris DW, Norton N, O'Donovan MC, Owen MJ, Richard C, Semwal P, Sobell JL, St Clair D, Straub RE, Thelma BK, Vallada H, Weinberger DR, Williams NM, Wood J, Zhang F, Devlin B, Nimgaonkar VL: Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry. 2006, 60: 152-162. 10.1016/j.biopsych.2006.02.015.PubMedCentralCrossRefPubMed
12.
Li D, He L: Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis. Eur J Hum Genet. 2006, 14: 1130-1135. 10.1038/sj.ejhg.5201680.CrossRefPubMed
13.
Guo S, Tang W, Shi Y, Huang K, Xi Z, Xu Y, Feng G, He L: RGS4 polymorphisms and risk of schizophrenia: an association study in Han Chinese plus meta-analysis. Neurosci Lett. 2006, 406: 122-127. 10.1016/j.neulet.2006.07.028.CrossRefPubMed
14.
Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L: Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008, 40: 827-834. 10.1038/ng.171.CrossRefPubMed
15.
Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003, 160: 636-645. 10.1176/appi.ajp.160.4.636.CrossRefPubMed
16.
Prasad KM, Chowdari KV, Nimgaonkar VL, Talkowski ME, Lewis DA, Keshavan MS: Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry. 2005, 10: 213-219. 10.1038/sj.mp.4001562.CrossRefPubMed
17.
Buckholtz JW, Meyer-Lindenberg A, Honea RA, Straub RE, Pezawas L, Egan MF, Vakkalanka R, Kolachana B, Verchinski BA, Sust S, Mattay VS, Weinberger DR, Callicott JH: Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. J Neurosci. 2007, 27: 1584-1593. 10.1523/JNEUROSCI.5112-06.2007.CrossRefPubMed
18.
Stefanis NC, Trikalinos TA, Avramopoulos D, Smyrnis N, Evdokimidis I, Ntzani EE, Ioannidis JP, Stefanis CN: Impact of Schizophrenia Candidate Genes on Schizotypy and Cognitive Endophenotypes at the Population Level. Biol Psychiatry. 2007, 62: 784-792. 10.1016/j.biopsych.2006.11.015.CrossRefPubMed
19.
Stefanis NC, Vitoratou S, Ntzoufras I, Smyrnis N, Evdokimidis I, CN S: Psychometric properties of the Greek version of the Schizotypal Personality Questionnaire (SPQ) in young male obligatory conscripts: A two years test-retest study. Pers Individ Dif. 2007, 41: 1275-1286. 10.1016/j.paid.2006.07.003.CrossRef
20.
Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L: The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988, 26: 223-238. 10.1016/0165-1781(88)90076-5.CrossRefPubMed
21.
Cannon TD, Huttunen MO, Lonnqvist J, Tuulio-Henriksson A, Pirkola T, Glahn D, Finkelstein J, Hietanen M, Kaprio J, Koskenvuo M: The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet. 2000, 67: 369-382. 10.1086/303006.PubMedCentralCrossRefPubMed
22.
Ettinger U, Picchioni M, Hall MH, Schulze K, Toulopoulou T, Landau S, Crawford TJ, Murray RM: Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study. Am J Psychiatry. 2006, 163: 543-545. 10.1176/appi.ajp.163.3.543.CrossRefPubMed
23.
Raven J: Revised Manual for Raven's Progressive Matrices and Vocabulary Scales. 1982, Windsor: NFER-Nelson
24.
Raine A: The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. 1991, 17: 555-564.CrossRefPubMed
25.
Stefanis NC, Smyrnis N, Avramopoulos D, Evdokimidis I, Ntzoufras I, Stefanis CN: Factorial composition of self-rated schizotypal traits among young males undergoing military training. Schizophr Bull. 2004, 30: 335-350.CrossRefPubMed
26.
Gevins A, Smith ME, Le J, Leong H, Bennett J, Martin N, McEvoy L, Du R, Whitfield S: High resolution evoked potential imaging of the cortical dynamics of human working memory. Electroencephalogr Clin Neurophysiol. 1996, 98: 327-348. 10.1016/0013-4694(96)00288-X.CrossRefPubMed
27.
Smyrnis N, Avramopoulos D, Evdokimidis I, Stefanis CN, Tsekou H, Stefanis NC: Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men. Biol Psychiatry. 2007, 61: 845-853. 10.1016/j.biopsych.2006.07.019.CrossRefPubMed
28.
Smyrnis N, Evdokimidis I, Stefanis NC, Avramopoulos D, Constantinidis TS, Stavropoulos A, Stefanis CN: Antisaccade performance of 1,273 men: effects of schizotypy, anxiety, and depression. J Abnorm Psychol. 2003, 112: 403-414. 10.1037/0021-843X.112.3.403.CrossRefPubMed
29.
Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, Verdoux H, Van Os J: Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002, 32: 347-358. 10.1017/S0033291701005141.CrossRefPubMed
30.
Cloninger CR, Svrakic DM, Przybeck TR: A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993, 50: 975-990.CrossRefPubMed
31.
Avramopoulos D, Stefanis NC, Hantoumi I, Smyrnis N, Evdokimidis I, Stefanis CN: Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry. 2002, 7: 706-711. 10.1038/sj.mp.4001070.CrossRefPubMed
32.
33.
Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed
34.
Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001, 68: 978-989. 10.1086/319501.PubMedCentralCrossRefPubMed
35.
Stephens M, Scheet P: Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 2005, 76: 449-462. 10.1086/428594.PubMedCentralCrossRefPubMed
36.
37.
Ioannidis JP: Effect of formal statistical significance on the credibility of observational associations. Am J Epidemiol. 2008, 168 (4): 374-390. 10.1093/aje/kwn156.CrossRefPubMed
38.
Park S, McTigue K: Working memory and the syndromes of schizotypal personality. Schizophr Res. 1997, 26: 213-220. 10.1016/S0920-9964(97)00051-0.CrossRefPubMed
39.
Suhr JA, Spitznagel MB: Factor versus cluster models of schizotypal traits. II: relation to neuropsychological impairment. Schizophr Res. 2001, 52: 241-250. 10.1016/S0920-9964(00)00185-7.CrossRefPubMed
40.
Dinn WM, Harris CL, Aycicegi A, Greene P, Andover MS: Positive and negative schizotypy in a student sample: neurocognitive and clinical correlates. Schizophr Res. 2002, 56: 171-185. 10.1016/S0920-9964(01)00230-4.CrossRefPubMed
41.
Siever LJ, ed.: Brain structure/function and the dopamine system in schizotypal personality disorder. 1995, New York: Cambridge University Press
42.
Linney YM, Murray RM, Peters ER, MacDonald AM, Rijsdijk F, Sham PC: A quantitative genetic analysis of schizotypal personality traits. Psychol Med. 2003, 33: 803-816. 10.1017/S0033291703007906.CrossRefPubMed
43.
Lin CC, Su CH, Kuo PH, Hsiao CK, Soong WT, Chen WJ: Genetic and environmental influences on schizotypy among adolescents in Taiwan: a multivariate twin/sibling analysis. Behav Genet. 2007, 37: 334-344. 10.1007/s10519-006-9104-5.CrossRefPubMed
44.
Fanous A, Gardner C, Walsh D, Kendler KS: Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Arch Gen Psychiatry. 2001, 58: 669-673. 10.1001/archpsyc.58.7.669.CrossRefPubMed
45.
Campbell DB, Ebert PJ, Skelly T, Stroup TS, Lieberman J, Levitt P, Sullivan PF: Ethnic Stratification of the Association of RGS4 Variants with Antipsychotic Treatment Response in Schizophrenia. Biol Psychiatry. 2008, 63 (1): 32-41. 10.1016/j.biopsych.2007.04.018.PubMedCentralCrossRefPubMed
46.
Ioannidis JP, Trikalinos TA, Khoury MJ: Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol. 2006, 164: 609-614. 10.1093/aje/kwj259.CrossRefPubMed
47.
Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat Genet. 2001, 29: 306-309. 10.1038/ng749.CrossRefPubMed
48.
Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS: Replicating genotype-phenotype associations. Nature. 2007, 447: 655-660. 10.1038/447655a.CrossRefPubMed
49.
Moonesinghe R, Khoury MJ, Liu T, Ioannidis JP: Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci USA. 2008, 105: 617-622. 10.1073/pnas.0705554105.PubMedCentralCrossRefPubMed
50.
51.
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N: Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004, 96: 434-442.CrossRefPubMed
Metadata
Title
Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level
Authors
Nicholas C Stefanis
Thomas A Trikalinos
Dimitrios Avramopoulos
Nikos Smyrnis
Ioannis Evdokimidis
Evangelia E Ntzani
Alex Hatzimanolis
John PA Ioannidis
Costas N Stefanis
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Behavioral and Brain Functions / Issue 1/2008
Electronic ISSN: 1744-9081
DOI
https://doi.org/10.1186/1744-9081-4-46

Other articles of this Issue 1/2008

Behavioral and Brain Functions 1/2008 Go to the issue

Review

Pharmacological and therapeutic directions in ADHD: Specificity in the PFC

Research

Altered behavior and digestive outcomes in adult male rats primed with minimal colon pain as neonates

Research

A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD

Research

Clinical heterogeneity among people with high functioning autism spectrum conditions: evidence favouring a continuous severity gradient

Research

Individual preferences modulate incentive values: Evidence from functional MRI

Research

Neural correlates of derived relational responding on tests of stimulus equivalence